Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-18T00:44:27.829Z Has data issue: false hasContentIssue false

Pharmacokinetic and pharmacodynamic interactions: from theory to practice

Published online by Cambridge University Press:  31 July 2026

M. Stuhec*
Affiliation:
Clinical Pharmacy and & Pharmacology, Medical Faculty Maribor, University Maribor, Maribor, Slovenia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Abstract

Drug–drug interactions (DDIs) are significant pharmacokinetic and pharmacodynamic consequences of concomitant treatment with two or more agents. DDIs are categorized as potential or clinically relevant. While many DDIs are identified as potential, only approximately 5% become clinically relevant. Various strategies—including the use of DDI checking tools, collaboration with clinical pharmacists, and systematic medication reviews—can reduce the occurrence of potential DDIs and, consequently, the risk of clinically significant DDIs. The speaker will present basic methods for detecting potential DDIs using a clinical case and will discuss the most recommended approaches to reducing clinically relevant DDIs in everyday clinical practice.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.